ACM
RCKTW icon

Altium Capital Management’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Altium Capital Management’s Portfolio RCKTW Stock Details RCKTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-731,561
Closed -$51.2K – 90
2024
Q3 		$51.2K Hold
731,561
– – 0.02% 63
2024
Q2 		$44.4K Hold
731,561
– – 0.02% 53
2024
Q1 		$219K Buy
+731,561
New +$232K 0.09% 47

Other funds holding RCKTW

BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Altium Capital Management's RCKTW Position: Q4 2024 in Review

Altium Capital Management sold out of Rocket Pharmaceuticals Warrant (RCKTW) in Q4 2024, closing a stake of 731,561 shares — an estimated $51.2K sold.

Altium Capital Management first reported a position in RCKTW in Q1 2024 and held it in 3 quarters. The position peaked at $219K in Q1 2024. 10 funds tracked by Wall St. Rank hold RCKTW as of Q4 2024.

  • Altium Capital Management reported no remaining Rocket Pharmaceuticals Warrant position as of Q4 2024 after selling out during the quarter.
  • Altium Capital Management sold 731,561 Rocket Pharmaceuticals Warrant shares in Q4 2024, an estimated $51.2K.
  • Altium Capital Management first reported a position in Rocket Pharmaceuticals Warrant in Q1 2024 and held it in 3 quarters.
  • Altium Capital Management's Rocket Pharmaceuticals Warrant position peaked at $219K in Q1 2024.
  • 10 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q4 2024.

Based on Altium Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.